A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to ...
Osteocytes, the most abundant cells in bone tissue, have long been underestimated in their functional capacity. Traditionally viewed as passive entities, recent research has illuminated their pivotal ...